These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34224329)

  • 21. Modeling the effect of sevoflurane on corrected QT prolongation: a pharmacodynamic analysis.
    Han DW; Park K; Jang SB; Kern SE
    Anesthesiology; 2010 Oct; 113(4):806-11. PubMed ID: 20808206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects.
    Mu S; Darpo B; Tang Z; Novotny W; Tawashi M; Xue H; Willett M; Lin L; Sahasranaman S; Ou YC
    Clin Transl Sci; 2020 Sep; 13(5):923-931. PubMed ID: 32144955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.
    Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Ho YL; Yang WS; Wu MS; Chen MF
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26199227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.
    Vargas HM; Rolf MG; Wisialowski TA; Achanzar W; Bahinski A; Bass A; Benson CT; Chaudhary KW; Couvreur N; Dota C; Engwall MJ; Michael Foley C; Gallacher D; Greiter-Wilke A; Guillon JM; Guth B; Himmel HM; Hegele-Hartung C; Ito M; Jenkinson S; Chiba K; Lagrutta A; Levesque P; Martel E; Okai Y; Peri R; Pointon A; Qu Y; Teisman A; Traebert M; Yoshinaga T; Gintant GA; Leishman DJ; Valentin JP
    Clin Pharmacol Ther; 2021 Feb; 109(2):310-318. PubMed ID: 32866317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.
    Shah RR
    Drug Saf; 2005; 28(11):1009-28. PubMed ID: 16231954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of QT Liability for PF-05251749 in the Presence of Potential Circadian Rhythm Modification.
    Huh Y; Chen D; Riley S; Chang C; Nicholas T
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):60-69. PubMed ID: 31749321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical analysis methods for QT/QTc prolongation.
    Ma H; Smith B; Dmitrienko A
    J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019.
    Cohen-Rabbie S; Berges AC; Rekić D; Parkinson J; Dota C; Tomkinson HK
    J Clin Pharmacol; 2021 Aug; 61(8):1106-1117. PubMed ID: 33624833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of dependent variable, time effect, covariates, and covariation structure in concentration-QTc modeling: A simulation study.
    Huang DP; Xiao S; Dang Q; Tsong Y
    Pharm Stat; 2018 Sep; 17(5):607-614. PubMed ID: 29956449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
    Panicker GK; Karnad DR; Kadam P; Badilini F; Damle A; Kothari S
    Br J Pharmacol; 2016 Apr; 173(8):1373-80. PubMed ID: 26784016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
    de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
    Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
    Malik M; Hnatkova K; Batchvarov V
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.
    Isbister GK; Page CB
    Br J Clin Pharmacol; 2013 Jul; 76(1):48-57. PubMed ID: 23167578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Study to Assess the Proarrhythmic Potential of Mirtazapine Using Concentration-QTc (C-QTc) Analysis.
    Gurkan S; Liu F; Chain A; Gutstein DE
    Clin Pharmacol Drug Dev; 2019 May; 8(4):449-458. PubMed ID: 30052325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
    Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
    J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.